
zzso zzso zzso has a poor outcome regardless of the treatment zzso Novel therapies are needed in an effort to improve zzso We present two children with zzso zzso treated with zzso and zzso both given every 2 zzso One patient also received zzso The first patient had stable disease and remains without progression after 30 zzso The second patient had a near complete response that was sustained for 18 zzso The regimen was well tolerated with minimal toxicity and provided prolonged zzso survival in these two zzso Prospective clinical trials are needed to evaluate the effectiveness of this zzso 

